Johnson & Johnson (JNJ) Return on Equity (2009 - 2026)
Johnson & Johnson recorded quarterly Return on Equity of 0.0% in Q1 2026, down 22.43% quarter-over-quarter from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.
Johnson & Johnson's Return on Equity history runs 18 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2023 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Equity came in at 0.0% for Q1 2026 at Johnson & Johnson, down from 0.0% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q3 2024.
- A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Equity.
- On a YoY basis, Return on Equity climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
- Johnson & Johnson's Return on Equity stood at 0.0% in 2022, then jumped by 1742 bps to 0.0% in 2023, then tumbled by 100 bps to 0.0% in 2024, then soared by 28554 bps to 0.0% in 2025, then fell by 22 bps to 0.0% in 2026.
- According to Business Quant data, Return on Equity over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 0.01% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -0.01% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 0.01% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 0.00% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 0.00% |
| Dec 28, 2025 | 0.00% |
| Sep 28, 2025 | 0.00% |
| Jun 29, 2025 | 0.00% |
| Mar 30, 2025 | 0.00% |
| Sep 29, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Oct 1, 2023 | 0.00% |
| Jul 2, 2023 | 0.00% |
| Apr 2, 2023 | 0.00% |
| Jan 1, 2023 | 0.00% |
| Oct 2, 2022 | 0.00% |
| Jul 3, 2022 | 0.00% |
| Apr 3, 2022 | 0.00% |
| Jan 2, 2022 | 0.00% |
| Oct 3, 2021 | 0.00% |
| Jul 4, 2021 | 0.00% |
| Apr 4, 2021 | 0.00% |
| Jan 3, 2021 | 0.00% |
| Sep 27, 2020 | 0.00% |
| Jun 28, 2020 | 0.00% |
| Mar 29, 2020 | 0.00% |
| Dec 29, 2019 | 0.00% |
| Sep 29, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 30, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jul 1, 2018 | 0.00% |
| Apr 1, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Oct 1, 2017 | 0.00% |
| Jul 2, 2017 | 0.00% |
| Apr 2, 2017 | 0.00% |
| Jan 1, 2017 | 0.00% |
| Oct 2, 2016 | 0.00% |
| Jul 3, 2016 | 0.00% |
| Apr 3, 2016 | 0.00% |
| Jan 3, 2016 | 0.00% |
| Sep 27, 2015 | 0.00% |
| Jun 28, 2015 | 0.00% |
| Mar 29, 2015 | 0.00% |
| Dec 28, 2014 | 0.00% |
| Sep 28, 2014 | 0.00% |
| Jun 29, 2014 | 0.00% |
| Mar 30, 2014 | 0.00% |
| Dec 29, 2013 | 0.00% |
| Sep 29, 2013 | 0.00% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | 0.00% |
| Dec 30, 2012 | 0.00% |
| Sep 30, 2012 | 0.00% |
| Jul 1, 2012 | 0.00% |
| Apr 1, 2012 | 0.00% |
| Jan 1, 2012 | 0.00% |
| Oct 2, 2011 | 0.00% |
| Jul 3, 2011 | 0.00% |
| Apr 3, 2011 | 0.00% |
| Jan 2, 2011 | 0.00% |
| Oct 3, 2010 | 0.00% |
| Jul 4, 2010 | 0.00% |
| Apr 4, 2010 | 0.00% |
| Jan 3, 2010 | 0.00% |
| Sep 27, 2009 | 0.00% |